Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The.

Slides:



Advertisements
Similar presentations
The analysis of survival data in nephrology. Basic concepts and methods of Cox regression Paul C. van Dijk 1-2, Kitty J. Jager 1, Aeilko H. Zwinderman.
Advertisements

Surviving Survival Analysis
Survival Analysis. Key variable = time until some event time from treatment to death time for a fracture to heal time from surgery to relapse.
Survival Analysis In many medical studies, the primary endpoint is time until an event occurs (e.g. death, remission) Data are typically subject to censoring.
If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
Survival Analysis. Statistical methods for analyzing longitudinal data on the occurrence of events. Events may include death, injury, onset of illness,
Introduction to Survival Analysis October 19, 2004 Brian F. Gage, MD, MSc with thanks to Bing Ho, MD, MPH Division of General Medical Sciences.
Departments of Medicine and Biostatistics
April 25 Exam April 27 (bring calculator with exp) Cox-Regression
Intermediate methods in observational epidemiology 2008 Instructor: Moyses Szklo Measures of Disease Frequency.
Lecture 3 Survival analysis. Problem Do patients survive longer after treatment A than after treatment B? Possible solutions: –ANOVA on mean survival.
NORMAL CURVE Needed for inferential statistics. Find percentile ranks without knowing all the scores in the distribution. Determine probabilities.
Biostatistics in Research Practice Time to event data Martin Bland Professor of Health Statistics University of York
Chapter 11 Survival Analysis Part 2. 2 Survival Analysis and Regression Combine lots of information Combine lots of information Look at several variables.
Chapter Topics Confidence Interval Estimation for the Mean (s Known)
Main Points to be Covered Cumulative incidence using life table method Difference between cumulative incidence based on proportion of persons at risk and.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Survival Analysis A Brief Introduction Survival Function, Hazard Function In many medical studies, the primary endpoint is time until an event.
Analysis of Complex Survey Data
Logistic Regression In logistic regression the outcome variable is binary, and the purpose of the analysis is to assess the effects of multiple explanatory.
Survival analysis Brian Healy, PhD. Previous classes Regression Regression –Linear regression –Multiple regression –Logistic regression.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 10: Survival Curves Marshall University Genomics Core.
17. Duration Modeling. Modeling Duration Time until retirement Time until business failure Time until exercise of a warranty Length of an unemployment.
Inference for proportions - Comparing 2 proportions IPS chapter 8.2 © 2006 W.H. Freeman and Company.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
1 Survival Analysis Biomedical Applications Halifax SAS User Group April 29/2011.
NASSER DAVARZANI DEPARTMENT OF KNOWLEDGE ENGINEERING MAASTRICHT UNIVERSITY, 6200 MAASTRICHT, THE NETHERLANDS 22 OCTOBER 2012 Introduction to Survival Analysis.
HSRP 734: Advanced Statistical Methods July 10, 2008.
G Lecture 121 Analysis of Time to Event Survival Analysis Language Example of time to high anxiety Discrete survival analysis through logistic regression.
Dr Laura Bonnett Department of Biostatistics. UNDERSTANDING SURVIVAL ANALYSIS.
Lecture 3 Survival analysis.
Population All members of a set which have a given characteristic. Population Data Data associated with a certain population. Population Parameter A measure.
1 Introduction to medical survival analysis John Pearson Biostatistics consultant University of Otago Canterbury 7 October 2008.
Design and Analysis of Clinical Study 11. Analysis of Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
SIMPLE TWO GROUP TESTS Prof Peter T Donnan Prof Peter T Donnan.
Applied Epidemiologic Analysis Fall 2002 Patricia Cohen, Ph.D. Henian Chen, M.D., Ph. D. Teaching Assistants Julie KranickSylvia Taylor Chelsea MorroniJudith.
Introduction to Survival Analysis Utah State University January 28, 2008 Bill Welbourn.
MBP1010 – Lecture 8: March 1, Odds Ratio/Relative Risk Logistic Regression Survival Analysis Reading: papers on OR and survival analysis (Resources)
Pro gradu –thesis Tuija Hevonkorpi.  Basic of survival analysis  Weibull model  Frailty models  Accelerated failure time model  Case study.
Medical Statistics as a science
§ 5.3 Normal Distributions: Finding Values. Probability and Normal Distributions If a random variable, x, is normally distributed, you can find the probability.
Introduction Sample Size Calculation for Comparing Strategies in Two-Stage Randomizations with Censored Data Zhiguo Li and Susan Murphy Institute for Social.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Going from data to analysis Dr. Nancy Mayo. Getting it right Research is about getting the right answer, not just an answer An answer is easy The right.
Survival Analysis approach in evaluating the efficacy of ARV treatment in HIV patients at the Dr GM Hospital in Tshwane, GP of S. Africa Marcus Motshwane.
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
Confidence Intervals for a Population Mean, Standard Deviation Unknown.
Topic 19: Survival Analysis T = Time until an event occurs. Events are, e.g., death, disease recurrence or relapse, infection, pregnancy.
SURVIVAL ANALYSIS PRESENTED BY: DR SANJAYA KUMAR SAHOO PGT,AIIH&PH,KOLKATA.
[Topic 11-Duration Models] 1/ Duration Modeling.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
Carolinas Medical Center, Charlotte, NC Website:
An introduction to Survival analysis and Applications to Predicting Recidivism Rebecca S. Frazier, PhD JBS International.
Comparison of Two Survival Curves
April 18 Intro to survival analysis Le 11.1 – 11.2
Survival curves We know how to compute survival curves if everyone reaches the endpoint so there is no “censored” data. Survival at t = S(t) = number still.
Survival Analysis: From Square One to Square Two Yin Bun Cheung, Ph.D. Paul Yip, Ph.D. Readings.
Statistical Inference for more than two groups
Statistics in medicine
Statistics 103 Monday, July 10, 2017.
SA3202 Statistical Methods for Social Sciences
HEART TRANSPLANTATION
HEART TRANSPLANTATION
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
LV5FU2-cisplatin followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: Preliminary results of a randomized phase III trial (FFCD.
Mintu P. Turakhia et al. JACEP 2016;2:
Biostatistics Primer: What a Clinician Ought to Know: Hazard Ratios
Where are we?.
Kaplan-Meier survival curves and the log rank test
HEART-LUNG TRANSPLANTATION
Presentation transcript:

Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The event does not necessarily have to be death The event does not necessarily have to be death It can be HRT and first thrombotic episode It can be HRT and first thrombotic episodeOR Exclusive breast feeding and another pregnancy OR Exercise and time to maximum tolerance.

Survival Analysis-2 Studying time to an event poses two difficulties: Time interval can vary from one subject to another. Also at the end of the study the event may not have occurred for many subjects. So time to event is not Normally distributed. In a long period of follow-up many subjects drop out. The only information we have about them is until last follow-up. These are Censored Observations.

Assumptions in Survival Analysis Survival prospects are assumed to stay the same throughout the study. Survival prospects are assumed to stay the same throughout the study. Subjects lost to follow-up have the same prognosis as those who continue with the study. Subjects lost to follow-up have the same prognosis as those who continue with the study. The probability that an individual is censored is unrelated to the probability that the individual suffers an event. The probability that an individual is censored is unrelated to the probability that the individual suffers an event. Anything which affects the hazard does so by the same proportion at all time. Anything which affects the hazard does so by the same proportion at all time.

Calculating Kaplan –Meier Survival Curve At the start of the study (t 0 ), proportion surviving = 1. Order survival time by increasing duration starting with the shortest. At each time interval from 1 to n survival time is calculated by S (ti) = ( ri – di / ri ) x S (ti -1) Where di = number of events at time ti For censored observations di = 0. ri = number alive just before it. For censored observations survival curve remains unchanged. At the next event the number ‘at risk’ is reduced by the number censored between the two events.

Hazard Curve H0 is the baseline hazard at time t i.e. h0(t) For any individual subject the hazard at time t is hi(t). Hi(t) is linked to the baseline hazard h0(t) by log e {hi(t)} = log e {h0(t)} + β 1 X1 + β 2 X2 +……..+ βpXp where X1, X2 and Xp are variables associated with the subject. Then hi(t) = h0(t) e β1X1 + β2X2 +….+ βpXp H0(t) represents the hazard for an individual where X1=X2=Xp=0. h(t) / h0(t) depends on the predictor variables and not on t h(t) / h0(t) is the hazard ratio

Data Analysis The study to be analysed is about comparing survival time of 49 patients with colorectal cancer after random allocation to γ linoleic acid and controls The study to be analysed is about comparing survival time of 49 patients with colorectal cancer after random allocation to γ linoleic acid and controls

Results - 1 Standard 95.0% Normal CI Mean(MTTF) Error Lower Upper Median = IQR = Q1 = Q3 = Kaplan-Meier Estimates Number Number Survival Standard 95.0% Normal CI Time at Risk Failed Probability Error Lower Upper Mean Time to Failure is the measure of the average survival time The Median gives the survival time for 50% of the subjects followed by survival probability table.

Results - 2 Comparison of Survival Curves Test Statistics Method Chi-Square DF P-Value Log-Rank Wilcoxon There is no significant difference in survival between the two groups.